Cell-Cell Communication, Messengers & Receptors, and Calcium Homeostasis
Cell–Cell Communication
Five canonical modes of inter-cell signalling explicitly discussed (listed in hierarchical order):- Cell–cell contact (direct contact via gap junctions)
Autocrine signalling
Paracrine signalling
Endocrine signalling (classic + neuro-endocrine variant)
Neuronal signalling (chemical synapses)
1. Cell–Cell Contact / Gap Junction Signalling
Physical continuity between cytoplasm of adjacent cells.
Structural unit: connexon (protein hexamer) forming a pore in each membrane; two connexons dock to create a gap junction channel.
Permits passage of ions & small molecules (less than or equal to 1 kDa); enables electrical and chemical coupling.
Functional examples- Synchronisation of smooth-muscle contraction (e.g., peristalsis along GI tract).
Coordinated contraction of cardiac myocytes -> unified heartbeat (functional syncytium).
2. Autocrine Signalling
Definition: Chemical messenger released by a cell acts back on the same cell that secreted it.
Key steps: synthesis -> release -> binding to surface receptor on identical cell -> intracellular signalling cascade.
Immune-system example (Type I Interferons):- Virus-infected cell produces IFN-α/β.
IFN binds its own IFN receptor -> up-regulates antiviral genes -> represses viral replication within the infected cell itself.
3. Paracrine Signalling
Messenger diffuses through interstitial fluid to nearby target cell(s).
Distinct emitting vs receiving cells; restricted spatial range.
Nitric-oxide (NO) exemplar in vascular wall:- Endothelial cells sense shear stress -> activate endothelial NO synthase -> release NO.
NO diffuses to adjacent vascular smooth-muscle -> activates soluble guanylate cyclase -> increases cGMP -> relaxation -> vasodilation.
4a. Endocrine Signalling (Classical)
Secretory cells arranged around fenestrated capillaries; tissue richly vascularised.
Hormone enters bloodstream -> distributes systemically -> acts on distant, often diverse tissues having the specific receptor.
Hallmarks: long-distance communication, low hormone concentration, high receptor specificity.
Thyroid-gland case study:- Secretes T3 (triiodothyronine) & T4 (thyroxine) -> systemic metabolic regulation & tissue maintenance.
Also produces calcitonin (peptide) -> calcium homeostasis.
4b. Neuro-Endocrine Signalling
Hybrid of neuronal & endocrine mechanisms.
Specific neurons (hypothalamic nuclei) synthesise hormones.
Action-potential arrival -> exocytosis of hormone into hypophyseal portal capillaries.
Hormone travels only a few millimetres to anterior pituitary -> binds receptors -> triggers secretion of secondary pituitary hormones (e.g., ACTH, TSH, GH).
5. Neuronal (Synaptic) Signalling
Chemical synapse structure: presynaptic terminal, synaptic cleft (approximately 20 nm), postsynaptic membrane.
Neurotransmitter stored in vesicles; release triggered by Ca2+ influx when an action potential depolarises the terminal.
Transmitter diffuses across the cleft, binds receptor (ionotropic/metabotropic) on target (neurone, muscle fibre, gland) -> fast, localised response.
Chemical Messengers & Receptors
Hormones vs Neurotransmitters
Hormones- Synthesised/secreted by specialised endocrine cells or organs.
Enter bloodstream in small amounts; act via high-affinity receptors.
Enable body-wide coordination.
Neurotransmitters- Synthesised/secreted by neurones.
Act locally at synapses (millisecond time-scale) for rapid signalling.
Chemical Classes of Hormones
Water-soluble (hydrophilic)- Cannot cross lipid bilayer unaided.
Includes catecholamines, most amines (except thyroid hormones), peptides & proteins (e.g., insulin, oxytocin).
Lipid-soluble (hydrophobic/lipophilic)- Freely cross membranes.
Comprise steroid hormones (e.g., testosterone) & thyroid hormones; also gaseous messenger NO.
Properties Comparison
Hydrophilic hormones
Synthesised & stored in vesicles -> ready for rapid exocytotic release.
Travel dissolved in plasma.
Fast onset, short half-life (minutes).
Hydrophobic hormones
Synthesised on demand; generally not stored.
Transported bound to carrier proteins in blood; only approximately 1% is free (biologically active).
Slower onset, longer duration (hours–days).
Receptor Specificity & Distribution
Every hormone binds a specific receptor -> limits action to cells expressing that receptor.
Receptors can be membrane-bound or intracellular (cytoplasmic/nuclear).
A single cell may express more than 10^3 copies of a given receptor; expression level modulates sensitivity.
Mechanisms of Action
Hydrophilic hormones (second-messenger pathway)
Hormone binds G-protein-coupled receptor (GPCR) on membrane -> receptor activation.
Activated GPCR stimulates adenylate cyclase -> ATP -> cAMP.
cAMP activates protein kinase A (PKA) or other kinases.
Kinases phosphorylate multiple proteins -> functional modulation (activation/inhibition).
Signal termination: phosphodiesterases degrade cAMP; phosphatases remove phosphate groups.
Feature: Signal amplification – one hormone molecule can yield 10^3 - 10^4 phosphorylated effectors.
Hydrophobic hormones (genomic pathway)
Free hormone diffuses through membrane.
Binds cytoplasmic or nuclear receptor -> hormone–receptor complex.
Complex acts as transcription factor binding hormone-response elements on DNA -> regulates gene transcription.
New mRNA translated -> new proteins -> altered cellular function.
Feature: Sustained change (hours-days) due to protein synthesis.
Calcium (Ca2+) Homeostasis
Physiological Significance
Essential mineral; majority (approximately 99%) stored in bone.
Critical for- Structural bone integrity.
Neurotransmitter exocytosis, synaptic signalling.
Excitation–contraction coupling in muscle.
Blood-clotting cascade, second-messenger functions.
Dysregulation -> hypercalcaemia / hypocalcaemia; symptoms span muscle twitches, seizures, arrhythmias, kidney stones, "abdominal moans & psychic groans".
Bone Composition
Specialised connective tissue; two morphologies:- Cortical (compact) bone.
Cancellous (spongy) bone with trabeculae + marrow.
ECM components- Organic (approximately 40%): approximately 90% type I collagen.
Inorganic (approximately 60%): calcium + phosphate forming hydroxyapatite crystals, chemical formula Ca10(PO4)6(OH)2 – embedded in collagen matrix.
Bone Cells & Remodelling
Osteoblasts: build bone (deposit collagen + mineral).
Osteoclasts: resorb bone (acidify & dissolve mineral).
Osteocytes: mature osteoblasts embedded in matrix; sense mechanical load, orchestrate remodelling.
Basal remodelling rate: approximately 20% of adult skeleton yearly.
Healthy state: osteoblast & osteoclast activities are coupled (balance).
Body Compartment Ca2+ Fluxes (at baseline)
Bone formation: 0.5 g day-1.
Bone resorption: 0.5 g day-1 (balanced).
Intestine & kidney can adjust absorption/re-absorption to compensate for deficit/excess.
Multiple regulatory checkpoints ensure plasma [Ca2+] stability.
Hormonal Regulation Summary
Hormone | Gland / Source | Primary Action on Plasma Ca2+ | Mechanisms |
|---|---|---|---|
Parathyroid hormone (PTH) | Chief cells, parathyroid gland | Increase | • Stimulate osteoclast-mediated bone resorption • Increase renal tubular re-absorption • Activate 1-α-hydroxylase in kidney => calcitriol synthesis |
Calcitonin | Parafollicular ("C") cells, thyroid | Decrease | • Stimulate osteoblast activity (deposition) • Inhibit osteoclasts • Decrease renal re-absorption |
Calcitriol (1,25-(OH)2D3) | Skin -> liver -> kidney (active form) | Increase | • Enhance intestinal Ca absorption • Synergises with PTH to activate osteoclasts • Modest renal re-absorption boost • Exerts negative feedback on PTH |
Cellular Sensors
Both chief cells & C-cells possess Calcium-Sensing Receptor Protein (CaSRP); detects extracellular [Ca2+] and modulates hormone secretion accordingly.
PTH Axis in Detail
Low plasma [Ca2+] sensed by CaSRP => elevated PTH secretion.
PTH targets- Bone: stimulates osteoclastogenesis (via RANKL pathway), inhibits osteoblast collagen synthesis -> increase resorption.
Kidney: increases distal-tubule Ca re-absorption, decreases phosphate re-absorption; up-regulates 1-α-hydroxylase -> converts 25-OH-D to calcitriol.
Net effect: increase plasma Ca2+, negative feedback to parathyroid gland.
Calcitonin Axis in Detail
High plasma [Ca2+] -> CaSRP on C-cells triggers calcitonin release (32-aa peptide).
Actions: stimulates osteoblast deposition; inhibits osteoclast resorption; enhances renal excretion.
Particularly important during childhood growth spurts & pregnancy/lactation.
Calcitriol Production & Action
Skin: UV converts 7-dehydrocholesterol -> cholecalciferol (vit D3).
Liver: 25-hydroxylation -> 25-OH-D.
Kidney: 1-α-hydroxylation (stimulated by PTH) -> 1,25-(OH)2D3 (calcitriol).
Calcitriol amplifies PTH effects on bone; markedly increases intestinal Ca absorption via TRPV6 channel up-regulation.
Excessive bone resorption due to chronic deficiency (e.g., inadequate sunlight/diet) predisposes to- Rickets (children), osteomalacia / osteoporosis (adults) -> compromised bone integrity.
Hormone Interactions
Permissive: PTH requires calcitriol to achieve full osteoclast activation.
Synergistic: PTH + calcitriol together enhance plasma Ca2+ more than either alone.
Antagonistic: Calcitonin acts in opposition to PTH when [Ca2+] is high.
Integrated Feedback Diagram (textual)
Low Ca2+ -> increase PTH -> bone resorption + renal conservation + increase calcitriol -> intestinal absorption.
High Ca2+ -> increase calcitonin -> bone deposition + renal excretion.
Calcitriol inhibits further PTH (negative feedback loop).
These bullet-point notes condense every critical concept, mechanism, example, quantitative reference, and physiological implication presented across the three learning objectives (LO1–LO3) while preserving hierarchical structure for efficient exam revision.